Medadvisor Ltd (AU:MDR) — Market Cap & Net Worth
Market Cap & Net Worth: Medadvisor Ltd (MDR)
Medadvisor Ltd (AU:MDR) has a market capitalization of $9.91 Million (AU$14.00 Million) as of June 16, 2026. Listed on the AU stock exchange, this Australia-based company holds position #27066 globally and #1321 in its home market, demonstrating a 4.76% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medadvisor Ltd's stock price AU$0.02 by its total outstanding shares 636521550 (636.52 Million). Review MDR liabilities breakdown to assess the company's total debt and financial obligations.
Medadvisor Ltd Market Cap History: 2015 to 2026
Medadvisor Ltd's market capitalization history from 2015 to 2026. Data shows change from $127.41 Million to $9.91 Million (-20.55% CAGR).
Medadvisor Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medadvisor Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.14x
Medadvisor Ltd's market cap is 0.14 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $108.77 Million | $1.43 Million | -$3.07 Million | 76.29x | N/A |
| 2017 | $149.17 Million | $4.24 Million | -$3.43 Million | 35.16x | N/A |
| 2018 | $108.77 Million | $6.60 Million | -$4.45 Million | 16.47x | N/A |
| 2019 | $159.84 Million | $8.24 Million | -$8.10 Million | 19.39x | N/A |
| 2020 | $159.88 Million | $9.60 Million | -$9.58 Million | 16.65x | N/A |
| 2021 | $177.90 Million | $38.77 Million | -$13.95 Million | 4.59x | N/A |
| 2022 | $117.10 Million | $67.75 Million | -$17.35 Million | 1.73x | N/A |
| 2023 | $96.83 Million | $97.96 Million | -$11.31 Million | 0.99x | N/A |
| 2024 | $101.34 Million | $122.11 Million | $792.13K | 0.83x | 127.93x |
| 2025 | $9.01 Million | $62.99 Million | -$60.21 Million | 0.14x | N/A |
Competitor Companies of MDR by Market Capitalization
Companies near Medadvisor Ltd in the global market cap rankings as of June 16, 2026.
Key companies related to Medadvisor Ltd by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #1031 globally with a market cap of $26.34 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1948 globally with a market cap of $12.16 Billion USD ( AU$17.19 Billion AUD).
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2150 globally with a market cap of $10.63 Billion USD.
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2573 globally with a market cap of $8.31 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1031 | Veeva Systems Inc Class A | NYSE:VEEV | $26.34 Billion | $162.17 |
| #1948 | Pro Medicus Ltd | AU:PME | $12.16 Billion | AU$164.55 |
| #2150 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $63.23 |
| #2573 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $8.31 Billion | $47.82 |
Medadvisor Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Medadvisor Ltd's market cap moved from $127.41 Million to $ 9.91 Million, with a yearly change of -20.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$9.91 Million | +10.00% |
| 2025 | AU$9.01 Million | -91.11% |
| 2024 | AU$101.34 Million | +4.65% |
| 2023 | AU$96.83 Million | -17.31% |
| 2022 | AU$117.10 Million | -34.18% |
| 2021 | AU$177.90 Million | +11.27% |
| 2020 | AU$159.88 Million | +0.03% |
| 2019 | AU$159.84 Million | +46.96% |
| 2018 | AU$108.77 Million | -27.08% |
| 2017 | AU$149.17 Million | +37.14% |
| 2016 | AU$108.77 Million | -14.63% |
| 2015 | AU$127.41 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of Medadvisor Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.91 Million USD |
| MoneyControl | $9.91 Million USD |
| MarketWatch | $9.91 Million USD |
| marketcap.company | $9.91 Million USD |
| Reuters | $9.91 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Medadvisor Ltd
Adheris Health Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, the United States, and the United Kingdom. The company offers THRiV, an omni-channel platform which provides pharmacy-driven patient and pharmacist engagement solutions to improve medication management. The company was formerly known as MedAdvisor Limited and changed its anm… Read more